- Home
- AIRG vs EVAX Comparison
AIRG vs EVAX Comparison
Compare AIRG & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIRG | EVAX |
|---|---|---|
| Founded | 1995 | 2008 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.7M | 42.7M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AIRG | EVAX |
|---|---|---|
| Price | $3.98 | $5.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $6.33 | ★ $12.33 |
| AVG Volume (30 Days) | 62.0K | ★ 99.2K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $54,737,000.00 | $7,650,000.00 |
| Revenue This Year | N/A | $128.77 |
| Revenue Next Year | $16.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 132.17 |
| 52 Week Low | $3.00 | $1.20 |
| 52 Week High | $9.12 | $12.15 |
Technical Indicators
Market Signals| Indicator | AIRG | EVAX |
|---|---|---|
| Relative Strength Index (RSI) | 46.67 | 46.34 |
| Support Level | $3.90 | $5.03 |
| Resistance Level | $4.20 | $6.12 |
| Average True Range (ATR) | 0.29 | 0.45 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 37.21 | 32.46 |
Price Performance
Historical ComparisonAbout AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.